1. Deny to sign the informed consent; 
2. type 1 diabetes; 
3. Family history of hypertriglyceridemia or fasting triglyceride>4.56 mmol/L; 
4. Have severe liver disease, kidney disease or cancer; 
5. Participating in the other clinical trial within 30 days; 
6. Other diseases or conditions, for which the doctor of the patients do not agree his or her participating.       
    

NCT01857167_exc_T3
Condition
type 1 diabetes
NCT01857167_exc_T4
Condition
hypertriglyceridemia
NCT01857167_exc_T5
Measurement
fasting triglyceride
NCT01857167_exc_T6
Value
>4.56 mmol/L
NCT01857167_exc_T7
Observation
Family history
NCT01857167_exc_T8
Scope
hypertriglyceridemia or fasting triglyceride>4.56 mmol/L
NCT01857167_exc_T9
Qualifier
severe
NCT01857167_exc_T10
Condition
liver disease
NCT01857167_exc_T11
Condition
kidney disease
NCT01857167_exc_T12
Condition
cancer
NCT01857167_exc_T14
Condition
Other diseases
NCT01857167_exc_T15
Condition
Other conditions
NCT01857167_exc_T18
Qualifier
for which the doctor of the patients do not agree his or her participating
NCT01857167_exc_T19
Scope
Other diseases or conditions